from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2539c/aroK

LFCtreatmentdescriptionclass of inhibitor

0.341

Amikacinug/mL Amikacintranslation

-0.610

Cap5-10ug/mL Capreomycintranslation

-0.827

Rox10-50 ug/mL Roxithromycintranslation

-0.129

SM2-5 ug/mL Streptomycintranslation

-0.543

Tet5-10 ug/mL Tetracyclinetranslation

0.438

Rif0.2-5ug/mL Rifampicintranscription

-0.441

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.946

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.827

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.059

CPZ10-50 ug/mL Chlorpromazinerespiration

0.761

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.046

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.553

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.659

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.196

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.046

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.035

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.088

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.092

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.034

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.141

KCN5-20 ug/mL Potassium cyaniderespiration

2.153

NaN30.2-2 mM Sodium aziderespiration

-0.240

Nigericin50 uM Nigericinrespiration

0.276

TRC10-150 ug/mL Triclosanrespiration

1.461

TRZ10-25 ug/mL Thioridazinerespiration

0.993

Valinomycin0.5-10 uM Valinomycinrespiration

-0.833

ZnSO42 mM ZnSO4respiration

0.441

menadione6-10 ug/mL Menadionerespiration

0.132

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.886

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.501

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.685

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.009

NRP_1Non-replicating persistence stage 1dosRassociated

-0.888

Amp0.2mg/mL AmpicillincellWall

-0.395

Cephalexin20-100 ug/mL CephalexincellWall

-0.357

Cerulenin0.32-5 ug/mL CerulenincellWall

0.297

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.117

EMB10-20 ug/mL EthambutolcellWall

-0.319

Eta12-40 ug/mL EthionamidecellWall

-0.216

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.216

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.884

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.565

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.322

BZA0.12 mg/mL BenzamidearomaticAmides

-0.042

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.100

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.935

H2O24 mM hydrogen peroxideDNAdamaging

-0.226

Levo10 ug/mL LevofloxacinDNAdamaging

-1.255

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.593

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.186

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.806

UVUV-irradiationDNAdamaging

0.119

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.475

Antimycin12.5-50 ug/mL Antimycin A?

-0.286

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.414

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.715

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.899

PA8240.2-2 ug/mL PA-824?

1.661

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.565

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.268

Verapamil50 uM Verapamil?

-0.208

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.480

methoxatin10-20 ug/mL Methoxatin?